TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$14.33
+0.32 (+2.28%)
Open$14.07
Previous Close$14.01
Day High$14.40
Day Low$13.87
52W High$21.03
52W Low$7.90
Volume—
Avg Volume453.1K
Market Cap996.22M
P/E Ratio33.95
EPS$0.56
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+74.1% upside
Current
$14.33
$14.33
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 66.62M | 63.32M | 591.55M |
| Net Income | -58,378,188 | -49,943,316 | 75.68M |
| Profit Margin | -87.6% | -83.3% | 12.8% |
| EBITDA | -46,808,693 | -42,270,207 | 125.32M |
| Free Cash Flow | — | — | 94.80M |
| Rev Growth | +5.2% | +5.2% | +8.8% |
| Debt/Equity | 0.17 | 0.17 | 1.02 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |